Glenn T Furuta1, F Dan Atkins2, Nancy A Lee3, James J Lee4. 1. Section of Pediatric Gastroenterology, Hepatology and Nutrition, Digestive Health Institute, Children's Hospital Colorado, Aurora, Colorado; Gastrointestinal Eosinophilic Diseases Program, Children's Hospital Colorado, Aurora, Colorado; Mucosal Inflammation Program, University of Colorado School of Medicine, Aurora, Colorado; Department of Pediatrics, University of Colorado School of Medicine, Denver, Colorado. 2. Gastrointestinal Eosinophilic Diseases Program, Children's Hospital Colorado, Aurora, Colorado; Section of Allergy, Immunology, and Rheumatology, Children's Hospital Colorado, Aurora, Colorado; Department of Pediatrics, University of Colorado School of Medicine, Denver, Colorado. 3. Division of Hematology and Oncology and Department of Biochemistry and Molecular Biology, Mayo Clinic Arizona, Scottsdale, Arizona; Division of Pulmonary Medicine and Department of Biochemistry and Molecular Biology, Mayo Clinic Arizona, Scottsdale, Arizona. 4. Division of Hematology and Oncology and Department of Biochemistry and Molecular Biology, Mayo Clinic Arizona, Scottsdale, Arizona; Division of Pulmonary Medicine and Department of Biochemistry and Molecular Biology, Mayo Clinic Arizona, Scottsdale, Arizona. Electronic address: jjlee@mayo.edu.
Abstract
OBJECTIVE: To review and highlight the unappreciated roles of eosinophils suggested by recent studies. DATA SOURCES: The literature, unpublished observations, and insights by the authors. STUDY SELECTIONS: Basic studies of mouse models and patient-based clinical studies of disease. RESULTS: Eosinophils are often thought of as destructive end-stage effector cells primarily linked to parasite host defense and dysregulated immune responses associated with allergic diseases, such as asthma. However, recent studies (ie, research focused on mechanisms of action and translational studies examining disease/inflammatory pathways) are suggesting far more complex roles for eosinophils. The goal of this review is 3-fold. (1) The authors examine the dynamic history of eosinophils and how physicians over time used this information to formulate defining hypotheses. Particular emphasis is placed on recent studies challenging the parochial view of host defense in favor of roles maintaining homeostasis through immune modulation and tissue remodeling/repair. (2) They discuss diagnostic approaches to assess eosinophils in clinical settings as a means of disease identification and subsequently as a measurement of disease severity. (3) They examine how contemporary views of eosinophils and their perceived roles in diseases have led to specific therapeutic strategies. The emphasis is to review the successes and failures of these strategies as the basis of formulating future clinical studies targeting eosinophils as potential therapies of disease. CONCLUSION: Despite the complexities of eosinophil-mediated activities and the less than overwhelming success of initial attempts targeting these cells, eosinophils remain a potentially important focal target of disease diagnosis and subsequent treatment strategies.
OBJECTIVE: To review and highlight the unappreciated roles of eosinophils suggested by recent studies. DATA SOURCES: The literature, unpublished observations, and insights by the authors. STUDY SELECTIONS: Basic studies of mouse models and patient-based clinical studies of disease. RESULTS: Eosinophils are often thought of as destructive end-stage effector cells primarily linked to parasite host defense and dysregulated immune responses associated with allergic diseases, such as asthma. However, recent studies (ie, research focused on mechanisms of action and translational studies examining disease/inflammatory pathways) are suggesting far more complex roles for eosinophils. The goal of this review is 3-fold. (1) The authors examine the dynamic history of eosinophils and how physicians over time used this information to formulate defining hypotheses. Particular emphasis is placed on recent studies challenging the parochial view of host defense in favor of roles maintaining homeostasis through immune modulation and tissue remodeling/repair. (2) They discuss diagnostic approaches to assess eosinophils in clinical settings as a means of disease identification and subsequently as a measurement of disease severity. (3) They examine how contemporary views of eosinophils and their perceived roles in diseases have led to specific therapeutic strategies. The emphasis is to review the successes and failures of these strategies as the basis of formulating future clinical studies targeting eosinophils as potential therapies of disease. CONCLUSION: Despite the complexities of eosinophil-mediated activities and the less than overwhelming success of initial attempts targeting these cells, eosinophils remain a potentially important focal target of disease diagnosis and subsequent treatment strategies.
Authors: Marc E Rothenberg; Amy D Klion; Florence E Roufosse; Jean Emmanuel Kahn; Peter F Weller; Hans-Uwe Simon; Lawrence B Schwartz; Lanny J Rosenwasser; Johannes Ring; Elaine F Griffin; Ann E Haig; Paul I H Frewer; Jacqueline M Parkin; Gerald J Gleich Journal: N Engl J Med Date: 2008-03-16 Impact factor: 91.245
Authors: Valeria Fabre; Daniel P Beiting; Susan K Bliss; Nebiat G Gebreselassie; Lucille F Gagliardo; Nancy A Lee; James J Lee; Judith A Appleton Journal: J Immunol Date: 2009-02-01 Impact factor: 5.422
Authors: Daniel Aguilar; Nathanael Lemonnier; Gerard H Koppelman; Erik Melén; Baldo Oliva; Mariona Pinart; Stefano Guerra; Jean Bousquet; Josep M Anto Journal: PLoS One Date: 2019-11-06 Impact factor: 3.240
Authors: Michelle Ma; Caroline M Percopo; Daniel E Sturdevant; Albert C Sek; Hirsh D Komarow; Helene F Rosenberg Journal: J Immunol Date: 2019-06-10 Impact factor: 5.422
Authors: Diego Bagnasco; Matteo Ferrando; Marco Caminati; Alice Bragantini; Francesca Puggioni; Gilda Varricchi; Giovanni Passalacqua; Giorgio Walter Canonica Journal: Drug Saf Date: 2017-07 Impact factor: 5.606
Authors: Claire Mesnil; Stéfanie Raulier; Geneviève Paulissen; Xue Xiao; Mark A Birrell; Dimitri Pirottin; Thibaut Janss; Philipp Starkl; Eve Ramery; Monique Henket; Florence N Schleich; Marc Radermecker; Kris Thielemans; Laurent Gillet; Marc Thiry; Maria G Belvisi; Renaud Louis; Christophe Desmet; Thomas Marichal; Fabrice Bureau Journal: J Clin Invest Date: 2016-08-22 Impact factor: 14.808